T1	Premise 45 159	A 62-year-old man with type 2 diabetes mellitus of 10 years of evolution is treated with metformin and sitagliptin
T2	Premise 161 222	He does little physical exercise and follows an adequate diet
T3	Premise 224 285	In the last 6 months he has lost weight and has more asthenia
T4	Premise 287 467	Her glycemic controls have deteriorated from baseline blood glucose levels of 110-140 mg/dL to 170-200 mg/dL, as well as her glycosylated hemoglobin which has gone from 7.1 to 8.5%
T5	Claim 529 624	Increase dietary protein and long-chain carbohydrate intake to improve asthenia and weight loss
T6	Claim 629 679	To associate a basal insulin dose to the treatment
T7	Claim 684 718	Associate with ascarbose treatment
T8	Claim 723 762	Substitute sitagliptin for pioglitazone
T9	Claim 767 803	Substitute metformin for glimepiride
T10	Claim 823 873	To associate a basal insulin dose to the treatment
R1	Support Ent1:T10 Ent2:T6	
T11	Premise 950 1062	Patient poorly controlled with metformin and sitagliptin with discrete cardinal symptoms (weight loss, asthenia)
T12	Claim 1064 1146	The best option is insulin to control cardinal symptoms and decrease HbA1c to < 7%
R2	Support Ent1:T11 Ent2:T10	
R3	Support Ent1:T11 Ent2:T12	
T13	Disease 600 608	asthenia
T14	Disease 613 624	weight loss
T15	Treatment 529 588	Increase dietary protein and long-chain carbohydrate intake
T16	Treatment 629 679	To associate a basal insulin dose to the treatment
T17	Treatment 684 718	Associate with ascarbose treatment
T18	Treatment 723 762	Substitute sitagliptin for pioglitazone
T19	Treatment 767 803	Substitute metformin for glimepiride
T20	Treatment 838 856	basal insulin dose
